Tag: AngioDynamics
AngioDynamics announces US FDA 510(k) clearance of Auryon XL radial access...
AngioDynamics today announced that the US Food and Drug Administration (FDA) has cleared the Auryon XL catheter, a 225cm radial access catheter, for use with...
Vascular News’ top 10 most popular stories of August 2022
The establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower extremity and arterial and venous interventions, results...
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced that it has received US Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system...
AngioDynamics receives 510(k) clearance for AlphaVac mechanical thrombectomy system
AngioDynamics recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the AlphaVac mechanical thrombectomy system.
According to...
“A new look at laser”: Positive initial data presented at ISET...
The Auryon atherectomy system (AngioDynamics) “represents an exciting new technology”, John Rundback (Advanced Interventional and Vascular Services, LLP, Teaneck, USA) opined at the International...
AngioDynamics announces presentation of positive safety, efficacy results from RAPID outcomes...
AngioDynamics has announced the safety and efficacy results from the RAPID (Registry of AngioVac system procedures in detail) database. Results were shared by principal...
First patient enrolled in PATHFINDER I registry examining Auryon atherectomy system
AngioDynamics has announced the enrolment of the first patient in the PATHFINDER I postmarket registry.
The PATHFINDER I registry is a pilot study to evaluate...
AngioDynamics launches PATHFINDER I registry to evaluate performance and clinical outcomes...
AngioDynamics has announced the launch of the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD-05), a pilot study to evaluate the safety and efficacy of...
AngioDynamics acquires Eximo Medical and its 355nm laser atherectomy technology
According to a press release, AngioDynamics has acquired Eximo Medical and its proprietary 355nm wavelength laser-technology platform for US$46 million in up-front consideration with...
AngioDynamics provides update on vascular access business
AngioDynamics has provided a corporate update and acknowledged a recent, favourable US District Court ruling that impacts its vascular access business.
A press release states...
